Skip to main content
. 2020 Mar 31;12(4):843. doi: 10.3390/cancers12040843

Figure 7.

Figure 7

Plasma miRNAs as key modulators of drug resistance, with altered expression in colon and rectal cancer, as well as for the global analysis comprising all colorectal cancers. (A) Venn diagram for the altered miRNAs which supposedly interfere with drug resistance in the analyzed groups; (B) heatmap generated using DIANA-miRPath v3.0, showing miRNA targets associated with biological processes related to the common miRNA signatures involved in drug resistance.